GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 229 filers reported holding GENMAB A/S in Q3 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $247 | -46.9% | 7,007 | -36.2% | 0.02% | 0.0% |
| Q1 2023 | $465 | 0.0% | 10,976 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $465 | -99.9% | 10,976 | -20.9% | 0.02% | 0.0% |
| Q3 2022 | $446,000 | +23.5% | 13,876 | +25.0% | 0.02% | +42.9% |
| Q2 2022 | $361,000 | -66.9% | 11,103 | -63.1% | 0.01% | -62.2% |
| Q1 2022 | $1,089,000 | +0.1% | 30,087 | +9.4% | 0.04% | +23.3% |
| Q4 2021 | $1,088,000 | -7.1% | 27,507 | +2.7% | 0.03% | -18.9% |
| Q3 2021 | $1,171,000 | +0.1% | 26,791 | -6.5% | 0.04% | -5.1% |
| Q2 2021 | $1,170,000 | +23.7% | 28,646 | -0.6% | 0.04% | +8.3% |
| Q1 2021 | $946,000 | -17.5% | 28,822 | +2.3% | 0.04% | -23.4% |
| Q4 2020 | $1,146,000 | +11.9% | 28,186 | +0.7% | 0.05% | -2.1% |
| Q3 2020 | $1,024,000 | -5.5% | 27,982 | -12.5% | 0.05% | -15.8% |
| Q2 2020 | $1,084,000 | +33.7% | 31,992 | -16.4% | 0.06% | +7.5% |
| Q1 2020 | $811,000 | +3.4% | 38,276 | +9.0% | 0.05% | +23.3% |
| Q4 2019 | $784,000 | +8.3% | 35,114 | -1.8% | 0.04% | -14.0% |
| Q3 2019 | $724,000 | – | 35,740 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |